Biuletyn COVID-19: Choroby układu krążenia

Ultraprocessed Food Again Linked to Increased CVD, Death
https://www.medscape.com/viewarticle/943200?nlid=138847_440&src=WNL_mdplsfeat_201229_mscpedit_publ&uac=73796MK&spon=42&impID=2788228&faf=1
In a longitudinal analysis of more than 22,000 men and women from southern Italy, those who consumed the most ultraprocessed food (UPF) had the highest risk for cardiovascular disease (CVD) and all-cause mortality, likely mediated through a diet high in sugar, researchers say.

19 grudnia 2020

Częstość występowania arytmii u pacjentów chorych na COVID-19.
https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03368-6?fbclid=IwAR2bqn8FFbd_Y0D0xe2BGtwxa6gmrqNL7vSF-pkg8X8L1KCLHqDH6qg8ogQ
Ogólna częstość występowania arytmii w COVID-19 pacjentów wynosiła 16,8%.

Możliwe mechanizmy arytmii mogą obejmować uszkodzenie serca w wyniku zaburzeń metabolicznych, niedotlenienie oraz zapalenie mięśnia sercowego.

29 września 2020

Trends in Cardiovascular Disease Prevalence by Income Level in the United States
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770958?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=092520
In this serial cross-sectional analysis of a nationally representative sample of 44 986 participants, decreases in cardiovascular disease prevalence primarily occurred in the highest-resources group, whereas the prevalence among the rest of the population declined at a much lower rate, stayed the same, or increased, depending on the cardiovascular condition.

This study found substantial and increasing disparities in CVD prevalence between the richest and poorest participants in the NHANES from 1999 to 2016, with lower CVD rate reported among the highest-resources group

Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018
https://jamanetwork.com/journals/jama/fullarticle/2770254?guestAccessKey=6559fa70-e5ce-4e4b-b356-1ac8d7ceb17c&utm_source=silverchair&utm_campaign=jama_network&utm_content=car_weekly_highlights&cmp=1&utm_medium=email
In this serial cross-sectional study that included 18 262 US adults aged 18 years or older with hypertension, with data weighted to be representative of the US population, the age-adjusted estimated proportion with controlled blood pressure increased from 31.8% in 1999-2000 to 48.5% in 2007-2008, remained stable through 2013-2014 (53.8%), and then declined to 43.7% in 2017-2018.

26 sierpnia 2020

First Evidence of SARS-CoV-2 in Heart Cells
https://www.medscape.com/viewarticle/936244?src=wnl_edit_tpal&uac=73796MK&impID=2524268&faf=1
SARS-CoV-2 has been found in cardiac tissue of a child from Brazil with multisystem inflammatory syndrome (MIS-C) related to COVID-19 who presented with myocarditis and died of heart failure.

24 sierpnia 2020

COVID-19 and vascular disease
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(20)30342-X/fulltext?dgcid=hubspot_email_newsletter_tlcoronavirus20&utm_campaign=tlcoronavirus20&utm_medium=email&_hsmi=93691434&_hsenc=p2ANqtz-9fc25eIdjASc_il6Yr4RHRf4UXou_0fya9QLorllQRuEPJl_zd7g1HcpeDMVvPJthEdHp2uLrGYoGx6nzRQwPG1iMWZdShqw_kLA3-N9kJ1OJzuEI&utm_content=93685298&utm_source=hs_email
Although SARS-CoV-2 does indeed infect pulmonary epithelial cells, it might also infect many other cell types, causing systematic inflammation with cytokine release and affecting multiple critical organs besides the lungs in severe cases.

30 lipca 2020

Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia
https://jamanetwork.com/journals/jama/fullarticle/2697696?resultClick=1
In this cohort of older adults, increased numbers of optimal cardiovascular health metrics and a higher cardiovascular health score were associated with a lower risk of dementia and lower rates of cognitive decline. These findings may support the promotion of cardiovascular health to prevent risk factors associated with cognitive decline and dementia

29 lipca 2020

Covid-19's impact on the heart: Two new studies suggest 'the plot thickening'
https://edition.cnn.com/2020/07/28/health/covid-heart-damage-two-studies/index.html?utm_term=1596021275632ec4d4f8d0e6c&utm_source=Coronavirus+Update+-+July+29%2C+2020&utm_medium=email&utm_campaign=230757_1596021275633&bt_ee=D%2Bmp4C%2B4cJezcIjr0kR861OkHkxZy6UrQZLVhz0SwNOxe%2B4lTM0%2BE7%2F%2BMu4kF4NB&bt_ts=1596021275633
"We've understood for a few months now that Covid-19 is not only a respiratory infection but a multi-system infection,"

28 lipca 2020

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)
https://jamanetwork.com/journals/jamacardiology/fullarticle/2768916?guestAccessKey=abfeb502-c1b6-4f59-a511-0171dc776f67&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamacardiology&utm_content=olf&utm_term=072720
In this study of a cohort of German patients recently recovered from COVID-19 infection, CMR revealed cardiac involvement in 78 patients (78%) and ongoing myocardial inflammation in 60 patients (60%), independent of preexisting conditions, severity and overall course of the acute illness, and time from the original diagnosis. These findings indicate the need for ongoing investigation of the long-term cardiovascular consequences of COVID-19.

Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
https://jamanetwork.com/journals/jamacardiology/fullarticle/2768914?guestAccessKey=9334b758-9fef-40a6-8074-bfbb30d864f1&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamacardiology&utm_content=olf&utm_term=072720
In this analysis of autopsy cases, viral presence within the myocardium could be documented. While a response to this infection could be reported in cases with higher virus load vs no virus infection, this was not associated with an influx of inflammatory cells. Future investigations should focus on evaluating the long-term consequences of this cardiac involvement

Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter
https://jamanetwork.com/journals/jamacardiology/fullarticle/2768915?guestAccessKey=bb6fd077-977e-4317-9405-3773b38b2944&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamacardiology&utm_content=olf&utm_term=072720
Yet, if this high rate of risk is confirmed, the pathologic basis for progressive left ventricular dysfunction is validated, and especially if longitudinal assessment reveals new-onset heart failure in the recovery phase of COVID-19, then the crisis of COVID-19 will not abate but will instead shift to a new de novo incidence of heart failure and other chronic cardiovascular complications.

12 lipca 2020

Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31528-2/fulltext?dgcid=hubspot_email_newsletter_tlcoronavirus20&utm_campaign=tlcoronavirus20&utm_medium=email&_hsmi=91154525&_hsenc=p2ANqtz-_YKo2J5Ljh8aHpVBS7zBN7wqOlHyRApyIZ4lBUanfjoaH6fxG74wpRUm3wTmh2p2VMhLozCIdsEozm6F9zEB8nWVwCfqpLrKx7Vck7j_9ov_JlSos&utm_content=91148052&utm_source=hs_email

9 lipca 2020

Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI Registry
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2767990?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=070820
These findings suggested that low to moderate alcohol drinking was associated with better global cognition scores, and these associations appeared stronger for white participants than for black participants. Studies examining the mechanisms underlying the association between alcohol drinking and cognition in middle-aged or older adults are needed

30 czerwca 2020

Niewydolność serca w siedmiu punktach
https://kardiologia.mp.pl/wiadomosci/240267,niewydolnosc-serca-w-siedmiu-punktach

Nadciśnienie w dobie COVID-19
https://www.mp.pl/webinaria/debaty/240192,nadcisnienie-w-dobie-covid-19
Zacznijmy od omówienia Pana nowego artykułu, który na początku maja ukazał się w New England Journal of Medicine, poświęconego kwestii nurtującej lekarzy na całym świecie: czy w dobie COVID-19 należy u osób z nadciśnieniem stosować inhibitory konwertazy angiotensyny (ACE) i antagonistów receptora angiotensyny (ARB)? Poprosimy o kilka słów na ten temat.

Mieliśmy więc do dyspozycji dane dotyczące ponad 6000 chorych na COVID-19, które porównaliśmy z liczącą ponad 30 000 osób grupą kontrolną (ten sam wiek, płeć, gmina zamieszkania). Okazało się, że chorzy na COVID-19 częściej stosowali ARB i inhibitory ACE, ale to samo dotyczyło wszystkich leków stosowanych w nadciśnieniu tętniczym, a także innych leków, które uwzględniała analiza, np. doustnych leków przeciwcukrzycowych, leków przeciwzakrzepowych czy przeciwpłytkowych. Po uwzględnieniu szeregu potencjalnych czynników zakłócających okazało się, że brak danych potwierdzających, jakoby inhibitory ACE lub ARB miały wpływ na ryzyko zachorowania na COVID-19 albo ciężkość przebiegu choroby

21 czerwca 2020

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
https://jamanetwork.com/journals/jama/fullarticle/2767669?guestAccessKey=000acf45-3da9-4eb6-9feb-87eef9841236&utm_source=silverchair&utm_campaign=jama_network&utm_content=car_weekly_highlights&cmp=1&utm_medium=email
Conclusions and Relevance Prior use of ACEI/ARBs was not significantly associated with COVID-19 diagnosis among patients with hypertension or with mortality or severe disease among patients diagnosed as having COVID-19. These findings do not support discontinuation of ACEI/ARB medications that are clinically indicated in the context of the COVID-19 pandemic.

A Characteristics Associated With Out-of-Hospital Cardiac Arrests and Resuscitations During the Novel Coronavirus Disease 2019 Pandemic in New York City
https://jamanetwork.com/journals/jamacardiology/fullarticle/2767649
A total of 5325 patients were included in the main analysis (2935 men [56.2%]; mean [SD] age, 71 [18] years), 3989 in the COVID-19 period and 1336 in the comparison period. The incidence of nontraumatic out-of-hospital cardiac arrests in those who underwent EMS resuscitation in 2020 was 3 times the incidence in 2019 (47.5/100 000 vs 15.9/100 000).

9 czerwca 2020

Badanie: ponad połowa pacjentów z zawałem unika zgłaszania się do szpitala z powodu strachu przed COVID-19
http://naukawpolsce.pap.pl/aktualnosci/news%2C82549%2Cbadanie-ponad-polowa-pacjentow-z-zawalem-unika-zglaszania-sie-do-szpitala-z
Badanie zostało przeprowadzone w połowie kwietnia wśród 3101 lekarzy lub pielęgniarek pracujących w szpitalach w 141 krajach świata. Większość z nich odnotowała, że przeciętnie o 50 proc. spadła liczba pacjentów zgłaszających się do szpitali z najcięższymi zawałami serca (tzw. zawał serca z uniesieniem odcinka ST), w porównaniu do okresu sprzed epidemii COVID-19.

Ponadto wśród osób z zawałem, które już zdecydowały się zgłosić do szpitala, niemal połowa (48 proc.) przybywała z opóźnieniem i poza tzw. oknem terapeutycznym, czyli poza optymalnym czasem, w którym terapia może odnieść największe korzyści. Tymczasem, opóźnienie w podjęciu leczenia interwencyjnego powoduje nieodwracalne uszkodzenie mięśnia sercowego i znacznie zwiększa ryzyko niewydolności serca i zgonu.

Niemal połowa z nich podkreślała, że przywrócenie przepływu krwi w tętnicy wieńcowej u pacjentów z zawałem było opóźnione z powodu strachu chorych przez COVID-19 i zbyt późnego zgłaszania się do szpitala.

Fear of COVID-19 keeping more than half of heart attack patients away from hospitals
Heart attack patients worldwide avoid hospitals or present too late to benefit from life-saving treatment
https://www.escardio.org/The-ESC/Press-Office/Press-releases/Fear-of-COVID-19-keeping-more-than-half-of-heart-attack-patients-away-from-hospitals
orginalny artykuł omówiony powyżej

7 czerwca 2020

Kardiolog: niewidzialna epidemia niewydolności serca w dobie pandemii COVID-19
http://naukawpolsce.pap.pl/aktualnosci/news%2C82521%2Ckardiolog-niewidzialna-epidemia-niewydolnosci-serca-w-dobie-pandemii-covid?fbclid=IwAR3V2EwNjA52Fl4zHKYHbPAFJ6paTwMI7pQsYEl_8vROa_i0BWGIjuCt4Bc
Niewidzialna epidemia w dobie pandemii – tak można określić aktualną sytuację w obszarze niewydolności serca – mówi kardiolog prof. Jadwiga Nessler, która podkreśla, że skala niewydolności serca rośnie, a w czasie restrykcji pacjenci nie zgłaszali się, "jakby zniknęli".

4 czerwca 2020

Potential Effects of Coronaviruses on the Cardiovascular System A Review
https://jamanetwork.com/journals/jamacardiology/fullarticle/2763846?guestAccessKey=6db8261b-fa51-4bea-9803-a1593b0e3e75&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamacardiology&utm_term=mostread&utm_content=olf-widget_06032020
Meanwhile, cardiovascular risk factors and conditions should be judiciously controlled per evidence-based guidelines.

3 czerwca 2020

U pacjentów z COVID-19 udary rzadsze niż się wydawało, ale częściej śmiertelne
https://www.mp.pl/neurologia/udar-mozgu/237561,u-pacjentow-z-covid-19-udary-rzadsze-niz-sie-wydawalo-ale-czesciej-smiertelne
Badanie ujawniło również, że osoby z obydwoma schorzeniami były młodsze, miały cięższe objawy i były co najmniej siedmiokrotnie bardziej narażone na zgon, niż ofiary udaru mózgu, które nie zostały zakażone koronawirusem.

27 maja 2020

Explaining the Association Between COVID-19 and Stroke
https://www.medscape.com/viewarticle/930457?nlid=135700_440&src=WNL_mdplsfeat_200526_mscpedit_publ&uac=73796MK&spon=42&impID=2396081&faf=1
I think our colleagues around the country have also seen a general decline in stroke patients overall, even though as I've seen and as you just pointed out, in those COVID-19 patients, certainly there seems to be some coagulation and ischemic issues. Have you see an overall decline in the non–COVID-19 stroke population?

25 maja 2020

Co wiemy, a czego jeszcze nie wiemy o związkach COVID-19 z chorobami układu krążenia
https://www.mp.pl/webinaria/237063,choroby-ukladu-krazenia-a-covid-19?fbclid=IwAR3T4qTYCvtzSv0907UZBVGFu0sdo8jWiEzBjh1PMG33SKzaK3JqaCOz3xs
Nagranie webinarium z 22 maja 2020

24 maja 2020

Co wiemy, a czego jeszcze nie wiemy o związkach COVID-19 z chorobami układu krążenia
https://www.mp.pl/webinaria/237063,choroby-ukladu-krazenia-a-covid-19

16 maja 2020

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31131-4/fulltext?dgcid=hubspot_email_newsletter_tlcoronavirus20&utm_campaign=tlcoronavirus20&utm_source=hs_email&utm_medium=email&utm_content=87997630&_hsenc=p2ANqtz-9x6OaAqFEU3B24R1YhIBxznLRH7dZjZ_tf1QdBC3HWWjFFlmxTFeNE3SnqwgFxvMcCYu6aS6erh3tNcH-SFATaaUxm
For the moment, we should applaud the remarkable achievement of investigators globally, in the face of considerable adversity, for rapidly generating scientific data that should diminish the speculation about the safety of RAAS inhibitors during this global COVID-19 pandemic and provide a degree of reassurance to patients and their doctors.

11 maja 2020

Choroby układu sercowo-naczyniowego w czasie pandemii COVID-19 w świetle aktualnych danych naukowych oraz stanowisk ESC i ESH
https://kardiologia.mp.pl/wytyczne/esc/covid/235857,choroby-ukladu-sercowo-naczyniowego-wczasie-pandemii-covid-19

Zespół profesora Voorsa zmierzył stężenie ACE2 w próbkach krwi pobranych od ponad 3500 pacjentów z niewydolnością serca z 11 krajów europejskich. Naukowcy rozpoczęli badanie przed pandemią koronawirusa, dlatego nie objęło ono pacjentów z COVID-19. Jednak, co ciekawe, gdy inne badania zaczęły wskazywać receptor na powierzchni komórek, ACE2, kluczowym w rozwoju koronawirusa, Voors i jego zespół zauważyli, że ich badania znacznie się pokrywają.

Wielu pacjentów z COVID-19 umiera na zakrzepicę
https://www.onet.pl/?utm_source=www.medonet.pl_viasg_medonet&utm_medium=referal&utm_campaign=leo_automatic&srcc=ucs&pid=2c55bfaa-23d0-49bd-9ab9-9ed3ee7b82e9&sid=4e9b6959-4f88-4e8b-9613-65de7438fe5a&utm_v=2

5 maja 2020

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2007621?articleTools=true&fbclid=IwAR2Qsfn_Qs6xfg6R9ZtK1pM1MxUwB22hEIXXAZoMUO2dM4Bww2-C9PNYvYc
Leczenie inhibitorami ACE zmniejsza ryzyko zgonu w COVID19. Międzynarodowy rejestr opublikowany w NEJM wskazuje na to, że wśród osób, które przeżyły zakażenie COVID19 było trzy krotnie więcej chorych leczonych ACEI

4 maja 2020

Cardiovascular Disease, Drug Therapy, and Mortality in Covid
https://www.nejm.org/doi/full/10.1056/NEJMoa2007621

Our study confirmed previous observations suggesting that underlying cardiovascular disease is associated with an increased risk of in-hospital death among patients hospitalized with Covid-19. Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with in-hospital death in this clinical context. (Funded by the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women’s Hospital.)

2 maja 2020

Trzy artykuły w JAMA nt. zagrożeń związanych ze stosowaniem hydroksychlorochiną

Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation
https://jamanetwork.com/journals/jamacardiology/fullarticle/2765632?guestAccessKey=c65202d8-1958-458f-ab67-d3eba3226e45&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamacardiology&utm_content=olf&utm_term=050120

QT Interval Prolongation and Hydroxychloroquine and Azithromycin in Hospitalized Patients With COVID-19
https://jamanetwork.com/journals/jamacardiology/fullarticle/2765631

Assessment of QT Intervals in a Case Series of Patients With COVID-19 Treated With Hydroxychloroquine Alone or in Combination With Azithromycin

2 maja 2920

Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation
https://jamanetwork.com/journals/jamacardiology/fullarticle/2765632?guestAccessKey=c65202d8-1958-458f-ab67-d3eba3226e45&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamacardiology&utm_content=olf&utm_term=050120
QT Interval Prolongation and Hydroxychloroquine and Azithromycin in Hospitalized Patients With COVID-19
https://jamanetwork.com/journals/jamacardiology/fullarticle/2765631
Assessment of QT Intervals in a Case Series of Patients With COVID-19 Treated With Hydroxychloroquine Alone or in Combination With Azithromycin

COVID-19 Linked to Large Vessel Stroke in Young Adults
https://www.medscape.com/viewarticle/929345
Physicians in New York City, which still leads the nation in reported COVID-19 cases, are reporting significantly more acute, large vessel strokes in young adults infected with COVID-19.
In a rapid communication to be published online April 29 in the New England Journal of Medicine, investigators led by Thomas Oxley, MD, PhD, department of neurosurgery, Mount Sinai Health System, report five cases of large vessel stroke over a 2-week period in COVID-19 patients under age 50 years. This represents a sevenfold increase in what would normally be expected.
The five cases had either no, or mild, COVID-19 symptoms.
Recently, investigators in the Netherlands found a "remarkably high" 31% rate of thrombotic complications among 184 critical care patients with COVID-19 pneumonia.
As previously reported by Medscape Medical News, physicians in hospitals across the United States and elsewhere have reported a significant drop in stroke patients since the COVID-19 pandemic took hold, suggesting patients may indeed be foregoing emergency

22 kwietnia 2020
Endothelial cell infection and endotheliitis in COVID-19
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30937-5/fulltext

Cardiovascular complications are rapidly emerging as a key threat in coronavirus disease 2019 (COVID-19) in addition to respiratory disease. The mechanisms underlying the disproportionate effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on patients with cardiovascular comorbidities, however, remain incompletely understood.

22 kwietnia 2020

Potencjalna szkodliwość chlorochiny i hydroksychlorochiny w leczeniu Covid-19
https://www.esculap.com/news/158844/potencjalna-szkodliwo-chlorochiny-i-hydroksychlorochiny-w-leczeniu-covid-19?utm_campaign=goniec1976&utm_source=esculap_lekarze&utm_medium=goniec&utm_content=L31&link_id=228139

2 kwietnia 2020

Eksperci: leki kardiologiczne nie powodują pogorszenia infekcji COVID-19
http://naukawpolsce.pap.pl/aktualnosci/news%2C81492%2Ceksperci-leki-kardiologiczne-nie-powoduja-pogorszenia-infekcji-covid-19.html
Pacjenci z chorobami sercowo-naczyniowymi nie powinni się obawiać, że leki kardiologiczne mogą powodować pogorszenie przebiegu infekcji COVID-19, nie ma żadnych potwierdzających to badań – podkreślają kardiolodzy w informacji przekazanej PAP.

31 marca 2020

Prof. Adam Witkowski: Miejmy świadomość, że koronawirus uszkadza serce
https://www.termedia.pl/mz/Prof-Adam-Witkowski-Miejmy-swiadomosc-ze-koronawirus-uszkadza-serce,37352.html
Pacjenci z chorobami sercowo-naczyniowymi są zdecydowanie bardziej narażeni na zgon z powodu koronawirusa. Co więcej, SARS-Cov-2 może nieodwracalnie uszkadzać serce osób wcześniej zdrowych - mówi prof. Adam Witkowski, prezes Polskiego Towarzystwa Kardiologicznego.

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
https://jamanetwork.com/journals/jamacardiology/fullarticle/2763524?guestAccessKey=2eacca38-1da1-4834-a118-f58a86c249b6&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamacardiology&utm_term=mostread&utm_content=olf-widget_03302020
Cardiac injury is a common condition among hospitalized patients with COVID-19 in Wuhan, China, and it is associated with higher risk of in-hospital mortality

23 marca 2020

High Blood Pressure Not Seen As Major Independent Risk For COVID-19=
https://www.npr.org/sections/coronavirus-live-updates/2020/03/20/818986656/high-blood-pressure-not-seen-as-major-independent-risk-for-covid-19?utm_campaign=storyshare&utm_source=facebook.com&utm_medium=social&t=1584894253798&t=1584951240862
The short answer appears to be: People with high blood pressure may be at increased risk, especially if it's not under control and they have other health problems. But if their blood pressure is under control and they don't have other risk factors, they probably are not at any greater peril, experts say

18 marca 2020

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? – rola receptorów ACE-2
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30116-8/fulltext
Human pathogenic coronaviruses (severe acute respiratory syndrome coronavirus [SARS-CoV] and SARS-CoV-2) bind to their target cells through angiotensin-converting enzyme 2 (ACE2), which is expressed by epithelial cells of the lung, intestine, kidney, and blood vessels.
The expression of ACE2 is substantially increased in patients with type 1 or type 2 diabetes, who are treated with ACE inhibitors and angiotensin II type-I receptor blockers (ARBs).

Priorytety w zakresie korzystania ze środków ochrony indywidualnej przygotowane przez ECDEC
https://www.mp.pl/covid19/ochrona/229645,priorytety-w-zakresie-korzystania-ze-srodkow-ochrony-indywidualnej

17 marca 2020

Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers
https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang
The Council on Hypertension strongly recommend that physicians and patients should continue treatment with their usual anti-hypertensive therapy because there is no clinical or scientific evidence to suggest that treatment with ACEi or ARBs should be discontinued because of the Covid-19 infection.

16 marca 2020

Nadciśnienie tętnicze i leki blokujące układ renina–angiotensyna a COVID-19.
Stanowisko European Society of Hypertension (12 marca 2020)
https://kardiologia.mp.pl/nadcisnienie-tetn/229375,nadcisnienie-tetnicze-i-leki-blokujace-uklad-reninaangiotensyna-a-covid-19-stanowisko-european-society-of-hypertension-12-marca-2020

Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers
https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang
PTK przygotowuje komunikat w tej sprawie – generalnie zgodny ze stanowiskiem European Society of Hypertension

Biuletyn COVID-19

Choroby układu krążenia

Brak komentarzy:

Prześlij komentarz